Objectives: Our objective was to assess the association between anxiety and risk of coronary heart disease (CHD).
Introduction
Research has demonstrated an association between psychological factors such as stress, and both the development of coronary heart disease (CHD) and CHD outcomes [1, 2] . Most studies have focused on the role of depression, with several meta-analyses indicating that depression is an independent risk factor for the development of CHD in the general population [3] , as well as a prognostic risk factor in CHD patients [4] .
While evidence suggests that anxiety also has an adverse impact on prognosis in CHD patients independent of depression [5] [6] [7] [8] , the role of anxiety as an etiological risk factor is less clear. While several studies suggest that anxiety may contribute to the development of CHD in initially healthy individuals [9] and found an effect on cardiac death [10] [11] [12] or incident myocardial infarction (MI) [13, 14] , others have found no association [15, 16] .
Meta-analytic research may help to resolve these inconsistencies but, to our knowledge, no recent meta-analysis has yet been conducted on the association between anxiety and incident heart disease. The present meta-analysis therefore focuses on the impact of anxiety on the development of CHD in initially healthy persons. The first objective of this study was to investigate the association of anxiety with incident CHD independent of traditional cardiovascular risk factors. The second objective was to examine whether the associations between anxiety and incident CHD were different for MI versus cardiac mortality as outcomes.
Methods
The aim was to assess the association between a comprehensive set of common anxiety constructs (including anxiety, panic, phobia, post-traumatic stress, and worry) and incident CHD. We identified all studies available by May 2009, on the development of CHD in anxious versus non-anxious persons. Methods for systematic identification, appraisal, synthesis and statistical aggregation of information, and reporting of results were chosen according to predetermined methods [17, 18] .
Literature search
The electronic databases MEDLINE, EMBASE and PSYCINFO (1980 ( -May 2009 were searched using the following terms: "(community or cohort or healthy persons or risk) and (anxiety or post traumatic stress disorder or tension or anxiety symptoms or anxiety disorder or panic or panic attacks or phobic anxiety or phobia or worry) and (mortality or coronary mortality or myocardial infarction or coronary heart disease or sudden cardiac death)". There were no language restrictions and both published and unpublished data were included. In addition, reference lists of included studies and review articles were checked to identify additional studies meeting selection criteria.
Selection
Two independent raters (A.R. and J.D.) identified studies meeting the following pre specified inclusion criteria:
1. Studies were prospective in nature, following a (non-psychiatric) cohort of initially healthy persons over time.
2. At baseline, studies had to include at least one self-report or interview-based assessment of anxiety symptoms or anxiety disorder; e.g., post traumatic stress disorder, tension, worry, phobic anxiety, panic, or generalized anxiety disorder.
Endpoints included cardiac mortality or MI.
Studies focusing explicitly on older persons (over 75 years old) were excluded.
During the selection procedure, in case of disagreement between the two raters, the four investigators discussed the difference of opinion until consensus was reached. When study samples included healthy persons combined with a small number of heart disease patients, these studies were included when the original study adjusted for the presence of medical conditions [15, 16, [19] [20] [21] [22] . Regarding multiple reports on the same dataset, only one paper was included based on the anxiety measure, study sample, endpoint, and follow-up period, preferring (in order of importance) general anxiety measured with a reliable and valid measure, multiple cardiac endpoints (e.g., cardiac mortality and MI), larger sample sizes, and longer follow-up periods. Regarding the different papers reporting on the Normative Aging Study, the study of Kubzansky et al. [23] was included because this study reported on general anxiety as measured with the Minnesota Multiphasic Personality Inventory (MMPI) and on non-fatal MI and cardiac mortality. We included both studies of Haines et al. [10, 24] , as they represented different outcomes. We retrieved the association between phobic anxiety and cardiac mortality from the later study (given the longer follow-up period) [24] , and the association between phobic anxiety and MI from the earlier study [10] . If necessary, the corresponding authors of the eligible studies were asked to provide additional information.
Information on sample size and characteristics (e.g. did the researchers include specific in-/exclusion criteria such as gender), anxiety assessment, endpoints, participation rate, percentage lost to follow-up, follow-up duration, bivariate and fully-adjusted relative risks and 95% confidence intervals (CI), and variables used in multivariable analysis was abstracted and evaluated. We did not weigh the contribution of each study to the meta-analysis on the basis of quality scoring for there are no validated measures of quality for observational studies and the use of subjective rating scales may lead to bias [25] .
Endpoints
We examined the association between anxiety and incident CHD. If a study reported on MI and cardiac mortality separately, we included cardiac mortality as endpoint [23, 26] . Concerning the papers of Haines et al., we included their study reporting on cardiac mortality [24] . We focused on hard medical endpoints and, if possible, kept angina out of our analysis [23, 27] because anxiety may be associated with the report of symptoms of chest pain without reflecting underlying CHD [27] . One included study reported on a broader endpoint, namely cardiovascular events (including cardiac death and non-fatal MI) [19] . We also examined the associations between anxiety and non-fatal MI and cardiac mortality (including sudden cardiac death and other cardiac death) separately.
Quantitative data synthesis
Data from all studies were pooled. We combined hazard ratios, relative risks and odds ratios from multivariable analyses. For one paper we had to recalculate the CI [22] because the log values for lower and upper limits were not symmetric. We suspected a relatively large heterogeneity in results given that the included studies differed in anxiety types, anxiety measures, and sample characteristics (e.g., gender). We therefore used the Random Effects Method to generate a summary estimate of effect estimates and tested the amount of heterogeneity with the Q test of homogeneity and the I² test, which indicates the proportion of total variance explained by heterogeneity.
In one study the relative risk of anxiety predicting CHD was expressed relative to a standard deviation increase in anxiety score [28] . We calculated a new relative risk and CI, based on the assumption of normal distribution, assuming that 20% of the sample experienced increased anxiety (mean anxiety prevalence of other included studies).
If a study included various scales of the Crown Crisp index, e.g. Haines et al. [10, 24] , the phobic anxiety scale was selected because it was most representative of other studies using the Crown Crisp Index [11, 26] . If the association between anxiety and CHD was assessed separately for men and women, we included that study twice with sample sizes according to the number of men and women in the study [22, 28] . In the studies from Eaker et al. [28, 29] , the tension scale was used because it reflects psychological symptoms of anxiety whereas the anxiety scale mainly reflects physiological arousal [28] that may be confounded by underlying cardiac disease.
We conducted a subgroup comparison between studies including all persons versus studies focusing on the contrast between high versus low anxiety subgroups.
If study outcomes were heterogeneous based on the I 2 test/Q test, the possible effects of anxiety type, follow-up period and study sample (healthy persons versus healthy and heart disease patients and men versus women) were studied.
Differences in effect estimates between the subgroups were assessed by comparing the pooled effect estimates using chi-squared analysis, comparing logarithms of these estimates. In order to evaluate the presence of publication bias, a funnel plot was constructed by plotting the effect measure against the inverse of its standard error. We used Egger's test of the intercept, the classic fail-safe N and Duval and Tweedie's Trim and Fill test to estimate the severity of publication bias. All analyses were performed with the program Comprehensive Meta-Analysis version 2.
Additional information by personal communication
The author of one included study was contacted for further information and supplied us with the multivariable hazard ratio (HR) of anxiety predicting cardiovascular events [19] .
Results
A flow diagram of the literature search is shown in Figure 1 
Incident CHD
Twenty studies that reported on incident CHD enclosed 249.846 persons. Mean follow-up period was 11.2 years, with follow-up periods ranging from 2.0 to 20.9
years. The mean age at baseline assessment ranged from 38 to 72 years. Eleven analyses reported on males, 7 on females and 4 on a combined sample of males and females. Fourteen analyses (70%) showed a statistically significant univariable association between anxiety and CHD and 10 (50%) were significant in multivariable analyses (table 2) .
The pooled HR for incident CHD (favoring cardiac death in case of multiple endpoints) was 1.26 (95% CI: 1.15-1.38; p<0.0001) when pooling multivariable and bivariate HRs, in case no multivariable HR was reported in the original study [27, 33] ( Figure 2 ).
Cardiac mortality and MI
Nine of the 21 included studies focused on cardiac mortality as a separate endpoint.
Five studies found a significant association between anxiety and cardiac mortality [11, 21, 26, 34, 35] , of which 3 remained significant in multivariable analyses [11, 34, 35] . The pooled multivariable HR for cardiac mortality was 1.48 (95% CI:
1.14-1.92; p=0.003). The heterogeneity was lower than for incident CHD (Q= 17.61; p= 0.024; I²= 54.57).
Five studies focused on non-fatal MI as a separate endpoint. Two studies found a significant association between general anxiety and MI [23, 33] , although one did not adjust for confounders [33] . A funnel plot of selected studies on the primary outcome suggested the presence of publication bias. Egger's test showed a significant asymmetry (p<0.0001).
The Fail-Safe N shows that another 389 null-studies are needed in order for the pvalue to exceed 0.05. According to the Trim and Fill test, the association between anxiety and CHD remains significant after imputing possible missing studies (HR:
1.16; 95% CI: 1.06-1.28) (Figure 3 ).
Discussion
This is the first meta-analysis focusing on the association of anxiety with the incidence of CHD in initially healthy individuals. The results show an association between anxiety and incident CHD with a 26% increase in risk. Anxiety was also specifically associated with cardiac mortality, with anxious persons having a 48% increased risk of cardiac death. There was a trend for an association between anxiety and incident non-fatal MI, but this association was based on only 5 studies. Subgroup analyses did not show any significant differences regarding study characteristics with significant associations for different types of anxiety, short and long-term follow-up and both men and women. Secondary analyses in the original studies, excluding heart disease patients at baseline, did also not affect the results [19, 20] .
Recently published studies using large databases demonstrated a significant association between anxiety and MI [36] and panic disorder and CHD [37, 38] .
Strength of this meta-analysis is the adjustment for covariates in most of the individual studies that were included. Only 2 studies did not adjust for covariates [27, 33] , of which one reported a significant association between anxiety and MI [33] .
All other studies adjusted for a variety of demographic variables, biological risk factors and health behaviors. After adjustment for these variables, the HRs decreased, but still remained significant.
It is important to compare the strength of the association between anxiety and incident CHD with other psychological constructs. A recent meta-analysis showed that depression was associated with a 46% increased risk of cardiovascular disease [39] , and the impact of depression on cardiac death (55% increased risk) was comparable to the impact of anxiety found in the present meta-analysis. Five studies on anxiety and CHD adjusted for depression in their analyses [20, 23, 34, 40, 41] , and four associations remained significant [20, 23, 34, 40] . In a study of Philips et al., subjects with both generalized anxiety disorder and major depressive disorder were at greatest risk of subsequent cardiac death, suggesting that anxiety and depression may also interact synergistically to affect CHD [21] . Anxiety and depression have a moderate to strong correlation and it is possible that anxiety and depression are both part of a larger and more stable psychological factor influencing heart disease, like negative affectivity [42, 43] . A recent meta-analysis focusing on the association of anger and hostility with CHD found a 19% increased risk, but (a) this association was no longer significant after adjusting for possible behavioral covariates [44] and (b) the association with CHD mortality was not significant [44] . This difference in anxiety and anger as potential predictors of cardiac death is of interest, and calls for confirmation in future research.
There are several potential mechanisms that may help to explain the adverse association between anxiety and CHD. Anxiety has been associated with progression of atherosclerosis [45] , decreased heart rate variability [46] and risk of ventricular arrhythmias [47, 48] . Research supports the risk of arrhythmias particularly in the case of phobic anxiety, with studies showing an association between phobic anxiety and sudden cardiac death, but not with non-fatal MI [11, 26] . More research is needed focusing on these possible mechanisms and the impact on different outcomes, particularly MI versus (sudden) cardiac death. Furthermore, anxiety is related to an unhealthy lifestyle in patients at risk of CHD [49] . In the present meta-analysis, unhealthy lifestyles (e.g. physical inactivity, increased body mass index and smoking)
were included as covariates, but they may also mediate the relationship between anxiety and CHD. This might indicate that the association between anxiety and CHD might be larger than reported here.
Anxiety can be treated effectively with cognitive behavior therapy and medications, e.g. benzodiazepines and selective serotonin reuptake inhibitors [50] .
Unfortunately, many patients do not receive adequate treatment [50] . Besides the impact of anxiety on disability and decreased quality of life, clinicians should be aware of the risk of anxiety associated with incident heart disease. Future research needs to investigate whether the treatment of anxiety has a significant beneficial effect on the incidence or course of cardiac disease [51] .
The results need to be considered in light of the study limitations. One important limitation in conducting a meta-analysis is the inevitability of combining data from studies that are not equally designed. Study samples were heterogeneous regarding age and gender and follow-up duration differed substantially across studies.
Further, different anxiety measures were included, some of which were not extensively validated. As a result, the heterogeneity in our results is substantial. Also, only one included paper focused on an anxiety disorder, namely generalized anxiety disorder [21] . It is important that studies use a valid and reliable anxiety measure and more research is needed to the association of anxiety disorders with heart disease development. However, the finding of an association between anxiety and CHD was quite consistent across studies. Also, studies reporting on the Normative Aging Study showed comparable results for different anxiety types, such as post traumatic stress disorder [52] and worry [13] , suggesting that a broad variety of anxiety symptoms influence incidence of CHD. Future research should focus on the specific aspects of anxiety that contribute to cardiac outcomes. Further, almost all studies were conducted in Western populations which might limit the generalization of the findings. Another limitation concerns the proneness of meta-analyses to publication bias. We found an indication for publication bias, suggesting that the association between anxiety and CHD might be smaller than reported here. However, after adjusting for this possible bias the results still show a reliable association of anxiety with CHD.
In summary, anxiety was found to be an independent risk factor for the incidence of 
